These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11246542)

  • 1. Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation.
    Ozcan M; Morton CT; Solovey A; Dandelet L; Bach RR; Hebbel RP; Slungaard A; Key NS
    Thromb Haemost; 2001 Feb; 85(2):250-5. PubMed ID: 11246542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.
    Key NS; Slungaard A; Dandelet L; Nelson SC; Moertel C; Styles LA; Kuypers FA; Bach RR
    Blood; 1998 Jun; 91(11):4216-23. PubMed ID: 9596669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tissue factor procoagulant activity in myelomonocytic cells inoculated by the agent of human granulocytic ehrlichiosis.
    Behl R; Klein MB; Dandelet L; Bach RR; Goodman JL; Key NS
    Thromb Haemost; 2000 Jan; 83(1):114-8. PubMed ID: 10669164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor expression in human leukemic cells.
    Hair GA; Padula S; Zeff R; Schmeizl M; Contrino J; Kreutzer DL; de Moerloose P; Boyd AW; Stanley I; Burgess AW; Rickles FR
    Leuk Res; 1996 Jan; 20(1):1-11. PubMed ID: 8632672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-induced expression and release of monocyte tissue factor in patients with haemophilia.
    Holstein K; Matysiak A; Witt L; Sievers B; Beckmann L; Haddad M; Renné T; Voigtlaender M; Langer F
    Ann Hematol; 2020 Jul; 99(7):1531-1542. PubMed ID: 32430703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells.
    Key NS; Bach RR; Vercellotti GM; Moldow CF
    Lab Invest; 1993 Jun; 68(6):645-51. PubMed ID: 8390591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-induced expression of tissue factor procoagulant activity in freshly isolated human mononuclear cells: implications for experimental use.
    Meisel SR; Shechter M; Xu XP; Edgington TS; Cercek B; Shah PK
    Clin Lab Haematol; 2003 Oct; 25(5):321-5. PubMed ID: 12974724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty.
    Johnson GJ; Leis LA; Bach RR
    Thromb Haemost; 2009 Oct; 102(4):728-34. PubMed ID: 19806259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human endothelial cell procoagulant activity in tumour models in vitro.
    Hewett PW; Murray C
    Int J Cancer; 1996 Jun; 66(6):784-9. PubMed ID: 8647650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.
    Aras O; Shet A; Bach RR; Hysjulien JL; Slungaard A; Hebbel RP; Escolar G; Jilma B; Key NS
    Blood; 2004 Jun; 103(12):4545-53. PubMed ID: 14988149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
    Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant canine interleukin-6 and interleukin-8 on tissue factor procoagulant activity in canine peripheral blood mononuclear cells and purified canine monocytes.
    Ogasawara S; Daddona JL; Trimpert J; Stokol T
    Vet Clin Pathol; 2012 Sep; 41(3):325-35. PubMed ID: 22724392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
    Topcuoglu P; Arat M; Dalva K; Ozcan M
    Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
    Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.